Seeking Alpha

Isis Pharmaceuticals (ISIS +2.9%) says it has filed a patent infringement lawsuit against...

Isis Pharmaceuticals (ISIS +2.9%) says it has filed a patent infringement lawsuit against Santaris Pharma A/S based upon Santaris' activities providing antisense drugs and antisense drug discovery services to several pharmaceutical companies.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector